Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: a joint analysis of five randomised trials on behalf of the EWALL.
Giebel S, Thomas X, Hallbook H, Geissler K, Boiron JM, Huguet F, Koller E, Jaeger U, Smedmyr B, Hellmann A, Holowiecki J. Giebel S, et al. Among authors: hallbook h. Eur J Cancer. 2012 Feb;48(3):360-7. doi: 10.1016/j.ejca.2011.11.023. Epub 2011 Dec 22. Eur J Cancer. 2012. PMID: 22196969
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia.
Hallböök H, Simonsson B, Ahlgren T, Björkholm M, Carneskog J, Grimfors G, Hast R, Karlsson K, Kimby E, Lerner R, Linder O, Linderholm M, Löfvenberg E, Malm C, Nilsson PG, Paul C, Stenke L, Stockelberg D, Tidefelt U, Turesson I, Uden-Blome AM, Vilen L, Wahlin A, Winquist I, Smedmyr B. Hallböök H, et al. Br J Haematol. 2002 Sep;118(3):748-54. doi: 10.1046/j.1365-2141.2002.03685.x. Br J Haematol. 2002. PMID: 12181041 Free article. Clinical Trial.
An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patients.
Nahi H, Hägglund H, Ahlgren T, Bernell P, Hardling M, Karlsson K, Lazarevic VLj, Linderholm M, Smedmyr B, Aström M, Hallböök H. Nahi H, et al. Among authors: hallbook h. Haematologica. 2008 Nov;93(11):1734-8. doi: 10.3324/haematol.13227. Epub 2008 Aug 25. Haematologica. 2008. PMID: 18728022 Free article.
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.
Juliusson G, Karlsson K, Lazarevic VLj, Wahlin A, Brune M, Antunovic P, Derolf A, Hägglund H, Karbach H, Lehmann S, Möllgård L, Stockelberg D, Hallböök H, Höglund M; Swedish Acute Leukemia Registry Group, the Swedish Acute Myeloid Leukemia Group, the Swedish Adult Acute Lymphoblastic Leukemia Group. Juliusson G, et al. Among authors: hallbook h. Cancer. 2011 Sep 15;117(18):4238-46. doi: 10.1002/cncr.26033. Epub 2011 Mar 8. Cancer. 2011. PMID: 21387283 Free article.
High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007.
Kozlowski P, Åström M, Ahlberg L, Bernell P, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A, Tomaszewska-Toporska B, Smedmyr B, Hallböök H. Kozlowski P, et al. Among authors: hallbook h. Haematologica. 2012 Sep;97(9):1414-21. doi: 10.3324/haematol.2011.057851. Epub 2012 Apr 17. Haematologica. 2012. PMID: 22511497 Free PMC article.
High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden.
Kozlowski P, Åström M, Ahlberg L, Bernell P, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A, Tomaszewska-Toporska B, Smedmyr B, Amini RM, Hallböök H; Swedish Adult ALL Group. Kozlowski P, et al. Among authors: hallbook h. Eur J Haematol. 2014;92(5):377-81. doi: 10.1111/ejh.12269. Epub 2014 Feb 21. Eur J Haematol. 2014. PMID: 24443846
Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study.
Bergfelt E, Kozlowski P, Ahlberg L, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A, Tomaszewska-Toporska B, Smedmyr B, Åström M, Amini RM, Hallböök H. Bergfelt E, et al. Among authors: hallbook h. Med Oncol. 2015 Apr;32(4):135. doi: 10.1007/s12032-015-0582-2. Epub 2015 Mar 22. Med Oncol. 2015. PMID: 25796502
45 results